Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Financing Activities: 2013-2024

Historic Cash from Financing Activities for Armata Pharmaceuticals (ARMP) over the last 11 years, with Dec 2024 value amounting to $35.0 million.

  • Armata Pharmaceuticals' Cash from Financing Activities rose 3055.83% to $6.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $12.5 million, marking a year-over-year increase of 43.59%. This contributed to the annual value of $35.0 million for FY2024, which is 35.25% down from last year.
  • As of FY2024, Armata Pharmaceuticals' Cash from Financing Activities stood at $35.0 million, which was down 35.25% from $54.0 million recorded in FY2023.
  • Armata Pharmaceuticals' Cash from Financing Activities' 5-year high stood at $54.0 million during FY2023, with a 5-year trough of $23.2 million in FY2020.
  • Its 3-year average for Cash from Financing Activities is $44.3 million, with a median of $44.0 million in 2022.
  • Per our database at Business Quant, Armata Pharmaceuticals' Cash from Financing Activities surged by 158.61% in 2020 and then plummeted by 35.25% in 2024.
  • Over the past 5 years, Armata Pharmaceuticals' Cash from Financing Activities (Yearly) stood at $23.2 million in 2020, then climbed by 9.94% to $25.5 million in 2021, then surged by 72.49% to $44.0 million in 2022, then increased by 22.66% to $54.0 million in 2023, then slumped by 35.25% to $35.0 million in 2024.